Optimizing treatment selection: outcomes of radical cystectomy in patients eligible for trimodal therapy

This study examines oncological and functional outcomes in a subset of patients eligible for trimodal therapy (TMT) within a large radical cystectomy (RC) cohort. It aims to determine whether TMT should be offered to all eligible patients, rather than exclusively to patients with significant comorbi...

Full description

Saved in:
Bibliographic Details
Main Authors: Mangold, Maurin Helen (Author) , Nientiedt, Malin (Author) , Waldbillig, Frank (Author) , Michel, Maurice Stephan (Author) , Carl, Nicolas (Author) , Grüne, Britta (Author) , Kriegmair, Maximilian (Author)
Format: Article (Journal)
Language:English
Published: 29 March 2025
In: World journal of urology
Year: 2025, Volume: 43, Issue: 1, Pages: 1-7
ISSN:1433-8726
DOI:10.1007/s00345-025-05566-9
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00345-025-05566-9
Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007/s00345-025-05566-9
Get full text
Author Notes:Maurin Helen Mangold, Malin Nientiedt, Frank Waldbillig, Maurice Stephan Michel, Nicolas Carl, Britta Grüne, Maximilian Christian Kriegmair
Description
Summary:This study examines oncological and functional outcomes in a subset of patients eligible for trimodal therapy (TMT) within a large radical cystectomy (RC) cohort. It aims to determine whether TMT should be offered to all eligible patients, rather than exclusively to patients with significant comorbidities who are at high perioperative risk.
Item Description:Gesehen am 08.07.2025
Physical Description:Online Resource
ISSN:1433-8726
DOI:10.1007/s00345-025-05566-9